Woonghee Y. Kim

Stockholm, AB, Sweden

Last Updated: 09/26/2026

Save publications for later

Sign Up

Not sure about your diagnosis?

Check Your Symptoms

Found 34 publications

Targeting PKLR and lipogenic enzymes through JNK inhibition to develop a therapeutic strategy for MASLD and MASH.

Targeting PKLR and lipogenic enzymes through JNK inhibition to develop a therapeutic strategy for MASLD and MASH.

Journal: Frontiers in pharmacology

Published: March 04, 2026

Development of Styryl-Modified 3,4-Dihydropyrimidin-2(1H)-ones as Potential Antitumor Agents.

Development of Styryl-Modified 3,4-Dihydropyrimidin-2(1H)-ones as Potential Antitumor Agents.

Journal: ChemMedChem

Published: November 24, 2025

Phospho-JNK agonists show promising effects for the treatment of hepatocellular carcinoma.

Phospho-JNK agonists show promising effects for the treatment of hepatocellular carcinoma.

Journal: iScience

Published: August 06, 2025

Anticancer effects and mechanisms of Pulsatilla chinensis, Bupleurum chinense and Polyporus umbellatus on human lung carcinoma and hepatoma cells.

Anticancer effects and mechanisms of Pulsatilla chinensis, Bupleurum chinense and Polyporus umbellatus on human lung carcinoma and hepatoma cells.

Journal: Computational and structural biotechnology journal

Published: February 26, 2025

Multi-tissue network analysis reveals the effect of JNK inhibition on dietary sucrose-induced metabolic dysfunction in rats.

Multi-tissue network analysis reveals the effect of JNK inhibition on dietary sucrose-induced metabolic dysfunction in rats.

Journal: eLife

Published: February 11, 2025

Synthesis and biological assessment of BUB1B inhibitors for the treatment of clear cell renal cell carcinoma.

Synthesis and biological assessment of BUB1B inhibitors for the treatment of clear cell renal cell carcinoma.

Journal: European journal of medicinal chemistry

Published: October 09, 2024

Unveiling the Molecular Mechanisms of Glioblastoma through an Integrated Network-Based Approach.

Unveiling the Molecular Mechanisms of Glioblastoma through an Integrated Network-Based Approach.

Journal: Biomedicines

Published: September 06, 2024

Corrigendum to "Discovery of therapeutic agents targeting PKLR for NAFLD using drug repositioning" [eBioMedicine, 2022;83:104214].

Corrigendum to "Discovery of therapeutic agents targeting PKLR for NAFLD using drug repositioning" [eBioMedicine, 2022;83:104214].

Journal: EBioMedicine

Published: June 29, 2024

Identification of SPP1 + macrophages as an immune suppressor in hepatocellular carcinoma using single-cell and bulk transcriptomics.

Identification of SPP1 + macrophages as an immune suppressor in hepatocellular carcinoma using single-cell and bulk transcriptomics.

Journal: Frontiers in immunology

Published: June 09, 2024

Discovery of Cell-Permeable Allosteric Inhibitors of Liver Pyruvate Kinase: Design and Synthesis of Sulfone-Based Urolithins.

Discovery of Cell-Permeable Allosteric Inhibitors of Liver Pyruvate Kinase: Design and Synthesis of Sulfone-Based Urolithins.

Journal: International journal of molecular sciences

Published: June 06, 2024

Novel drug targets and molecular mechanisms for sarcopenia based on systems biology.

Novel drug targets and molecular mechanisms for sarcopenia based on systems biology.

Journal: Biomedicine & pharmacotherapy = Biomedecine & pharmacotherapie

Published: April 24, 2024

Design and synthesis of novel JNK inhibitors targeting liver pyruvate kinase for the treatment of non-alcoholic fatty liver disease and hepatocellular carcinoma.

Design and synthesis of novel JNK inhibitors targeting liver pyruvate kinase for the treatment of non-alcoholic fatty liver disease and hepatocellular carcinoma.

Journal: Bioorganic chemistry

Published: March 06, 2024

Showing 1-12 of 34

Last Updated: 09/26/2026